Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology.
Beaton DE, Maxwell LJ, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March LM, Simon LS, Singh JA, Strand V, Tugwell P. Beaton DE, et al. Among authors: grosskleg s. J Rheumatol. 2019 Aug;46(8):1028-1035. doi: 10.3899/jrheum.181218. Epub 2019 Feb 1. J Rheumatol. 2019. PMID: 30709952 Free article.
Current State of Reporting Pain Outcomes in Cochrane Reviews of Chronic Musculoskeletal Pain Conditions and Considerations for an OMERACT Research Agenda.
Maxwell LJ, Wells GA, Simon LS, Conaghan PG, Grosskleg S, Scrivens K, Beaton DE, Bingham CO 3rd, Busse JW, Christensen R, Goel N, Jüni P, Kaiser U, Lyddiatt A, Mease PJ, Ostelo RW, Phillips K, Sapunar D, Singh JA, Strand V, Taylor AM, Terwee CB, Tugwell P. Maxwell LJ, et al. Among authors: grosskleg s. J Rheumatol. 2015 Oct;42(10):1934-1942. doi: 10.3899/jrheum.141423. Epub 2015 Sep 15. J Rheumatol. 2015. PMID: 26373562 Free PMC article.
Introduction.
Tugwell P, Grosskleg S, Shea B, Beaton D, Wells GA. Tugwell P, et al. Among authors: grosskleg s. J Rheumatol. 2017 Oct;44(10):1511-1514. doi: 10.3899/jrheum.170659. J Rheumatol. 2017. PMID: 28966171 No abstract available.
Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials.
Andersen KM, Cheah JTL, March L, Bartlett SJ, Beaton D, Bingham CO 3rd, Brooks PM, Christensen R, Conaghan PG, D'Agostino MA, de Wit M, Dueck AC, Goodman SM, Grosskleg S, Hill CL, Howell M, Mackie SL, Richards B, Shea B, Singh JA, Strand V, Tugwell P, Wells GA, Simon LS. Andersen KM, et al. Among authors: grosskleg s. J Rheumatol. 2019 Aug;46(8):1053-1058. doi: 10.3899/jrheum.181123. Epub 2019 Jan 15. J Rheumatol. 2019. PMID: 30647191 Free article.
Introduction.
March L, Richards B, Gill M, Brooks PM, Shea BJ, Beaton DE, Maxwell LJ, Tunis SR, Grosskleg S, Tugwell P. March L, et al. Among authors: grosskleg s. J Rheumatol. 2019 Aug;46(8):962-968. doi: 10.3899/jrheum.190105. J Rheumatol. 2019. PMID: 31371663 No abstract available.
Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.
Maxwell LJ, Beaton DE, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit M, Gossec L, March L, Simon LS, Singh JA, Strand V, Tugwell P. Maxwell LJ, et al. Among authors: grosskleg s. J Rheumatol. 2019 Aug;46(8):1014-1020. doi: 10.3899/jrheum.181097. Epub 2019 Feb 15. J Rheumatol. 2019. PMID: 30770502 Free article.
21 results